Skip to content

Cardiac rehabilitation for people with chronic stable angina

Cardiac rehabilitation for people with chronic stable angina (ACTIVATE): a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10054455
Enrollment
518
Registered
2021-09-16
Start date
2021-12-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina pectoris Circulatory System Chronic stable angina

Interventions

People with long-term stable angina will be recruited and divided into two groups. One group will receive usual care
the other group will undertake a rehabilitation programme in addition to usual care. Participants in undertaking the rehabilitation programme will be given access to ‘ActivateYourHeart’ (https://www.a

Sponsors

University of Liverpool
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 125 Years

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Chronic stable angina with at least 2 out of 3 of the following features: 2.1. Constricting central chest pain 2.2. Precipitated by exertion or emotional stress 2.3. Relieved by rest or glyceryl trinitrate spray 3. Documented coronary artery disease on angiography with =70% stenosis of coronary arteries based on invasive coronary angiography, computerised tomography angiography, or reversible myocardial ischaemia on myocardial perfusion testing 4. Revascularisation procedures not planned and treated with medical treatments only. Including people with previous MI, or previous revascularisation procedure who may have attended cardiac rehabilitation in the past.

Exclusion criteria

Exclusion criteria: 1. History of myocardial infarction (MI) within the last 12 months on electronic health record search 2. History of revascularisation procedure within the last 12 months, or planned at the time of study consent 3. Participation in cardiac rehabilitation programme within the last 12 months, or planned at time of study recruitment 4. Significant co-morbidities (as deemed by person confirming eligibility) that would limit participation in the exercise based rehabilitation programme 5. Refractory angina on maximal medical therapy

Design outcomes

Primary

MeasureTime frame
Physical limitations measured using the UK Version of Seattle Angina Questionnaire (SAQ-7) Physical Limitation domain at baseline, 6, and 12 months

Secondary

MeasureTime frame
1. Dyspnea measured using the Rose Dyspnea Scale at baseline, 6, and 12 months 2. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) at baseline, 6, and 12 months 3. Perceived self-efficacy measured using the Generalised Self-Efficacy scale at baseline, 6, and 12 months 4. Physical activity measured with the ActivPAL accelerometer over 7 days at baseline, 6, and 12 months 5. Health–related physical activity measured using the International Physical Activity Questionnaire (IPAQ) at baseline, 6, and 12 months 6. Exercise capacity measured using the Incremental Shuttle Walk Test at baseline, 6, and 12 months 7. Quality of life measured using the EuroQol 5-Dimension 5-Level Quality of Life questionnaire (EQ-5D-5L) at baseline, 6, and 12 months 8. Service utilisation measured using the Client Service Receipt Inventory (CSRI) at baseline, 6, and 12 months

Countries

England, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 29, 2026